chemistry

Neuraminidase inhibitor

Neuraminidase inhibitor is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Neuraminidase inhibitor rather than just read about it. In short: Neuraminidase inhibitors (NAIs) are a class of drugs which block the neuraminidase enzyme. They are a commonly used antiviral drug type against influenza.

Key takeaways

Neuraminidase inhibitor belongs to chemistry; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Neuraminidase inhibitor to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Neuraminidase inhibitor from memory before moving on to harder problems.

Reference excerpt

Neuraminidase inhibitors (NAIs) are a class of drugs which block the neuraminidase enzyme. They are a commonly used antiviral drug type against influenza. Viral neuraminidases are essential for influenza reproduction, facilitating viral budding from the host cell. Oseltamivir (Tamiflu), zanamivir (Relenza), laninamivir (Inavir), and peramivir belong to this class. Unlike the M2 inhibitors, which work only against the influenza A virus, NAIs act against both influenza A and influenza B. The NAIs oseltamivir and zanamivir were approved in the US and Europe for treatment and prevention of influenza A and B. Peramivir acts by strongly binding to the neuraminidase of the influenza viruses and inhibits activation of neuraminidase much longer than oseltamivir or zanamivir. However, laninamivir in the cells is slowly released into the respiratory tract, resulting in long-lasting anti-influenza virus activity. Thus the mechanism of the long-lasting activity of laninamivir is basically different from that of peramivir. The efficacy was highly debated in recent years. However, after the pandemic caused by H1N1 in 2009, the effectiveness of early treatment with neuraminidase inhibitors in reducing serious cases and deaths was reported in various countries. In countries where influenza-like illness is treated using NAIs on a national level, statistical reports show a low fatality record for symptomatic illness because of the universal implementation of early treatment using this class of drugs. Although oseltamivir is widely used in these countries, there have been no outbreaks caused by oseltamivir-resistant viruses and also no serious illness caused by oseltamivir-resistant viruses has ever been reported. The United States Centers for Disease Control and Prevention continues to recommend the use of oseltamavir treatment for people at high risk for complications and the elderly and those at lower risk who present within 48 hours of first symptoms of infection. Common side effects include nausea and vomiting. The abnormal behaviors of children after taking oseltamivir that have been reported may be an extension of delirium or hallucinations caused by influenza. It occurs in the early stages of the illness, such as within 48 hours after onset of the illness. Therefore, children with influenza are advised to be observed by their parents until 48 hours after the onset of the influenza illness, regardless of whether the child is treated with NAIs. However, studies performed since the FDA label warning was placed indicate that these neuropsychiatric events are related to influenza itself rather than oseltamivir. Oseltamivir treatment has been associated with a reduction in neuropsychiatric events and oseltamivir prophylaxis does not have an increased risk of neuropsychiatric events compared to those without influenza.

Specific neuraminidase inhibitors Laninamivir Oseltamivir (Tamiflu) Peramivir (Rapivab) Zanamivir (Relenza)

Structures of the viral neuraminidase inhibitors in use

Natural products Cyanidin-3-sambubioside (extracted from black elderberry) Coptisine Berberine

See also Discovery and development of neuraminidase inhibitors

References

External links Media related to Neuraminidase inhibitors at Wikimedia Commons

Illustrations

Worked examples

Example 1 — a first encounter with Neuraminidase inhibitor

Start with the simplest possible case. Write down what Neuraminidase inhibitor claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Neuraminidase inhibitor before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Neuraminidase inhibitor ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Neuraminidase inhibitor

In research: Neuraminidase inhibitor appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Neuraminidase inhibitor in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Neuraminidase inhibitor is common in secondary-school and first-year university syllabi. It links to neighbouring topics Carbohydrate chemistry, Neuraminidase inhibitors, so understanding it makes those chapters shorter.
In everyday life: Look for Neuraminidase inhibitor outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Neuraminidase inhibitor” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Neuraminidase inhibitor in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Neuraminidase inhibitor means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Neuraminidase inhibitor out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Neuraminidase inhibitor in simple terms?

Neuraminidase inhibitors (NAIs) are a class of drugs which block the neuraminidase enzyme. They are a commonly used antiviral drug type against influenza.

Why does Neuraminidase inhibitor matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Neuraminidase inhibitor?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Neuraminidase inhibitor.